1. Some Considerations on the WHO Histological Classification of Laryngeal Neoplasms

   • Alfio Ferlito
   • Kenneth O. Devaney
   • Henrik Hellquist

   Review Open access 22 May 2019 Pages: 1511 - 1517

2. Management of Fibrosing Interstitial Lung Diseases

   • Toby M. Maher
   • Wim Wuyts

   Review Open access 22 May 2019 Pages: 1518 - 1531

3. How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview

   • Theodoros Empeslidis
   • Matthew Storey
   • Anastasios G. Konstas

   Review Open access 17 May 2019 Pages: 1532 - 1548

4. Advances in Clinical Cardiology 2018: A Summary of Key Clinical Trials

   • Katie Linden
   • Conor McQuillan
   • Ian B. A. Menown

   Review Open access 07 May 2019 Pages: 1549 - 1573

   

5. A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH)

   • Manca Povsic
   • On Yee Wong
   • Juliana Bottomley

   Review Open access 07 May 2019 Pages: 1574 - 1594

   

6. YINGLONG: A Multicenter, Prospective, Non-Interventional Study Evaluating the Safety and Tolerability of Ticagrelor in Chinese Patients with Acute Coronary Syndrome

   • Xin Du
   • Yang Zheng
   • the YINGLONG study investigators

   Original Research Open access 22 May 2019 Pages: 1595 - 1605

   

7. Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study

   • Fritz H. Hengerer
   • Gerd U. Auffarth
   • Ina Conrad-Hengerer

   Original Research Open access 22 May 2019 Pages: 1606 - 1617

   

8. Absolute Bioavailability of Esaxerenone and Food Effects on its Pharmacokinetics After a Single Oral Dose in Healthy Japanese Subjects: An Open-Label Crossover Study

   • Akifumi Kurata
   • Hidetoshi Furuie
   • Hitoshi Ishizuka

   Original Research Open access 22 May 2019 Pages: 1618 - 1627

   

9. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries

   • Gesine van Mark
   • Stefanie Lanzinger
   • Peter Bramlage

   Original Research 22 May 2019 Pages: 1628 - 1641

   

10. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers

    • Sook Jin Seong
    • Boram Ohk
    • Young-Ran Yoon

    Original Research 22 May 2019 Pages: 1642 - 1656

    

11. Objective and Subjective Effects of a Prototype Nasal Dilator Strip on Sleep in Subjects with Chronic Nocturnal Nasal Congestion

    • John R. Wheatley
    • Terence C. Amis
    • Gilbert Shanga

    Original Research Open access 22 May 2019 Pages: 1657 - 1671

    

12. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study

    • Daniel Aletaha
    • Andrew J. Epstein
    • Remo Panaccione

    Original Research Open access 17 May 2019 Pages: 1672 - 1683

    

13. Drug Survival of Biological Therapies for Psoriasis Treatment in Germany and Associated Costs: A Retrospective Claims Database Analysis

    • Jörg Mahlich
    • Aranzazu Alba
    • Wiebke K. Peitsch

    Original Research 17 May 2019 Pages: 1684 - 1699

    

14. Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties

    • Jihoon Yun
    • Jihyun Kim
    • Su Jin Park

    Original Research Open access 17 May 2019 Pages: 1700 - 1714

    

15. Cost-Effectiveness of the Use of Autologous Cell Harvesting Device Compared to Standard of Care for Treatment of Severe Burns in the United States

    • Stacey Kowal
    • Eliza Kruger
    • Andrew Quick

    Original Research Open access 07 May 2019 Pages: 1715 - 1729

    

16. Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study

    • Lynn R. Webster
    • Eric R. Kinzler
    • Stefan Aigner

    Original Research Open access 07 May 2019 Pages: 1730 - 1740

    

17. Multiple Sclerosis Performance Test: Technical Development and Usability

    • Jane K. Rhodes
    • David Schindler
    • Richard A. Rudick

    Original Research Open access 03 May 2019 Pages: 1741 - 1755

    

18. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler^® to Budesonide/Formoterol Easyhaler^®

    • Jörgen Syk
    • Ines Vinge
    • Paula Rytilä

    Original Research Open access 02 April 2019 Pages: 1756 - 1769

    

19. Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler^® to Budesonide/Formoterol Easyhaler^®

    • Jörgen Syk
    • Ines Vinge
    • Paula Rytilä

    Correction Open access 09 June 2019 Pages: 1770 - 1770

20. Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis

    • Matteo Bassetti
    • Daniele Roberto Giacobbe
    • Jill Massey

    Brief Report Open access 16 May 2019 Pages: 1771 - 1777

21. Improving the Timely Detection of Bladder and Kidney Cancer in Primary Care

    • Yin Zhou
    • Garth Funston
    • Fiona M. Walter

    Practical Approach Open access 17 May 2019 Pages: 1778 - 1785

    

22. Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia

    • Tawfeg Ben-Omran
    • Luis Masana
    • Raul D. Santos

    Case Series Open access 17 May 2019 Pages: 1786 - 1811

    

23. Different Solutions for Damaged Nasotracheal Tube during Maxillofacial Surgery: A Case Series

    • Alba Piroli
    • Tommaso Cutilli
    • Antonella Paladini

    Case Series 07 May 2019 Pages: 1812 - 1816